目的:分析地氯雷他定联合舒利迭治疗咳嗽变异性哮喘的疗效。方法:将我院2009年2月~2013年2月收治的咳嗽变异性哮喘患者90例随机分为治疗组和对照组,各45例,对两组的疗效进行统计分析。结果:治疗组有效率为95.5%,对照组为75.5%,两组比较,差异有统计学意义(P<0.05)。结论:地氯雷他定联合舒利迭治疗咳嗽变异性哮喘疗效确切。 Objective: To analyze the curative effect of desloratadine combined with seretide on cough variant asthma. Methods: Ninety patients with cough variant asthma admitted from February 2009 to February 2013 in our hospital were randomly divided into treatment group and control group, 45 cases in each group. The curative effect of the two groups were statistically analyzed. Results: The effective rate was 95.5% in the treatment group and 75.5% in the control group. There was significant difference between the two groups (P <0.05). Conclusion: Desloratadine combined with seretide is effective in treating cough variant asthma.